ONGC shares fell over 3% after Axis Capital initiated coverage with a sell rating and a Rs 205 target, citing production decline, weak oil price outlook, and high subsidiary debt, implying about 14% downside from current levels.Read More

Shares of Kaynes Technology rebounded sharply after a prolonged correction, supported by a positive brokerage view from Elara Capital, which said recent concerns around accounting and cash flows were overstated and did not alter the company’s long-term growth outlook.Read More

Corona Remedies shares rose sharply on December 15, extending gains after a blockbuster IPO debut. Strong institutional demand, consistent profitability and a focused chronic therapy portfolio have supported post-listing momentum, even as the stock trades at rich valuations, keeping investors watchful of execution and margin sustainability.Read More

Global markets face a crucial week as political negotiations in Europe, a wave of delayed US economic data and key central-bank meetings converge, shaping expectations for growth, inflation and monetary policy in the year ahead.Read More

The Reserve Bank of India will buy bonds worth 500 billion rupees ($5.52 billion) on Thursday and has included more liquid papers, including the 7.18% 2033 and former benchmark 6.33% 2035 bonds.Read More

The BOJ’s closely watched quarterly “tankan” survey, released on Monday, showed sentiment hitting a four-year high among big manufacturers, reinforcing expectations for the central bank to resume raising rates on Friday.Read More

Indian equity markets could see earnings surprises over the next one to two years as Nifty valuations hover near long-term averages, says Complete Circle Capital’s Aditya Kondawar. Banking, manufacturing and autos may lead gains, while small and midcaps could recover as trade deals progress and credit growth accelerates India’s push toward a $8 trillion economy.Read More

Corona Remedies Share Price: Corona Remedies debuted on Dalal Street with a significant 38.42% premium, opening at Rs 1,470 on NSE and Rs 1,452 on BSE. The Rs 655 crore IPO, entirely an offer for sale, was oversubscribed 144.5 times, highlighting strong investor confidence in its business model and niche market leadership.Read More

Wakefit Innovations listed flat on Monday, debuting at Rs 195 on the NSE and slightly lower on the BSE, in line with muted grey market expectations. The Rs 1,289-crore IPO saw moderate demand, with investors cautious amid aggressive valuations and a limited profitability track record despite strong brand presence.Read More

Tata Steel shares: The company announced plans to boost domestic capacity by nearly 50%, including a 4.8-million-tonne addition, aimed at strengthening market leadership and securing long-term raw material supplies.Read More